标题
Denosumab: an Emerging Therapy in Pediatric Bone Disorders
作者
关键词
RANKL, OPG, Osteoporosis, Giant cell tumors, Osteogenesis imperfecta, Bone turnover rebound, Hypercalcemia
出版物
Current Osteoporosis Reports
Volume 15, Issue 4, Pages 283-292
出版商
Springer Nature
发表日期
2017-06-22
DOI
10.1007/s11914-017-0380-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pharmacological and biological therapeutic strategies for osteogenesis imperfecta
- (2016) Ronit Marom et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Osteogenesis Imperfecta Type VI in Individuals from Northern Canada
- (2016) Leanne Ward et al. CALCIFIED TISSUE INTERNATIONAL
- Severe rebound-associated vertebral fractures after denosumab discontinuation: nine clinical cases report
- (2016) Olivier Lamy et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteogenesis imperfecta
- (2016) Antonella Forlino et al. LANCET
- Hypercalcemia after discontinuation of long-term denosumab treatment
- (2016) A. S. Koldkjær Sølling et al. OSTEOPOROSIS INTERNATIONAL
- Hypocalcaemia in patients with metastatic bone disease treated with denosumab
- (2015) Jean-Jacques Body et al. EUROPEAN JOURNAL OF CANCER
- The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease
- (2015) Ingo J. Diel et al. EUROPEAN JOURNAL OF CANCER
- Severe hypercalcemia following denosumab treatment in a juvenile patient
- (2015) Nokitaka Setsu et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years
- (2015) Telma Palomo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteosclerosis induced by denosumab
- (2015) Eisuke Kobayashi et al. LANCET
- Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports
- (2015) B. Aubry-Rozier et al. OSTEOPOROSIS INTERNATIONAL
- The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study
- (2015) S. Papapoulos et al. OSTEOPOROSIS INTERNATIONAL
- Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics
- (2015) A. W. Popp et al. OSTEOPOROSIS INTERNATIONAL
- Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review
- (2015) J. Selga et al. OSTEOPOROSIS INTERNATIONAL
- Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone
- (2015) Nathan Gossai et al. PEDIATRIC BLOOD & CANCER
- Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy
- (2015) George R. Matcuk et al. SKELETAL RADIOLOGY
- RANK pathway in giant cell tumor of bone: pathogenesis and therapeutic aspects
- (2015) Pan-Feng Wu et al. TUMOR BIOLOGY
- Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study
- (2014) Javier Martin-Broto et al. ACTA ONCOLOGICA
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
- (2014) Aliya A Khan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of Denosumab on the Growing Skeleton in Osteogenesis Imperfecta
- (2014) Heike Hoyer-Kuhn et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Trials Express:Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
- (2014) Toshitaka Nakamura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Denosumab Treatment and Discontinuation on Human Growth Plates
- (2014) Howard D. Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab for Treatment of Hypercalcemia of Malignancy
- (2014) Mimi I. Hu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Management of Central Giant Cell Granuloma With Subcutaneous Denosumab Therapy
- (2014) Aparna Naidu et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- The Clinical Approach Toward Giant Cell Tumor of Bone
- (2014) L. van der Heijden et al. ONCOLOGIST
- Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI
- (2014) Heike Hoyer-Kuhn et al. Orphanet Journal of Rare Diseases
- Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response
- (2014) Dominic W. Pelle et al. Translational Research
- Signaling Between Tumor Cells and the Host Bone Marrow Microenvironment
- (2013) Natasa Kovacic et al. CALCIFIED TISSUE INTERNATIONAL
- Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts
- (2013) Tobias Lange et al. EUROPEAN SPINE JOURNAL
- Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials
- (2013) Wei-Xiang Qi et al. International Journal of Clinical Oncology
- Effects of RANK-Ligand Antibody (Denosumab) Treatment on Bone Turnover Markers in a Girl With Juvenile Paget's Disease
- (2013) Corinna Grasemann et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab Treatment of Metastatic Giant-Cell Tumor of Bone in a 10-Year-Old Girl
- (2013) Nicole A. Karras et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study
- (2013) Sant Chawla et al. LANCET ONCOLOGY
- Population Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours
- (2012) Leonid Gibiansky et al. CLINICAL PHARMACOKINETICS
- Bone Modeling and Remodeling
- (2012) Ego Seeman CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Denosumab treatment for fibrous dysplasia
- (2012) Alison M Boyce et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A single-dose study of denosumab in patients with various degrees of renal impairment
- (2012) Geoffrey A Block et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial
- (2012) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Post-Transplantation Hypercalcemia in Osteopetrosis
- (2012) Rukshana Shroff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Skeletal biology over the life span: A view from the surfaces
- (2011) James H. Gosman et al. AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY
- Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis
- (2011) Liviawati Sutjandra et al. CLINICAL PHARMACOKINETICS
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
- (2011) N. B. Watts et al. OSTEOPOROSIS INTERNATIONAL
- Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
- (2011) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
- (2009) David L Kendler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders
- (2008) Stuart H. Ralston BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Comparison of the Effect of Denosumab and Alendronate on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial
- (2008) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Comparison of Effects of the Bisphosphonate Alendronate Versus the RANKL Inhibitor Denosumab on Murine Fracture Healing
- (2008) Louis C Gerstenfeld et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
- (2008) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started